The purpose of this study is to evaluate the long-term outcome of patients with multivessel coronary artery disease who underwent percutaneous transluminal coronary angioplasty (PTCA) or coronary artery bypass graft surgery (CABG) five years previous. The application of mechanical therapy for severe coronary artery disease (CAD) has increased substantially in the past decade. In 1988 in the U.S., approximately 250,000 patients with coronary artery disease were treated with percutaneous transluminal coronary angioplasty (PTCA) and nearly as many patients received coronary artery bypass graft (CABG) surgery (National Center for Health Statistics, 1988). Both methods provide relief from severe angina but the relative indications for PTCA and CABG in patients with multivessel coronary artery disease is unclear. PTCA is less invasive but in patients with more advanced multivessel disease, it appears to have complication rates comparable to those of CABG. Early restenosis necessitates an additional procedure within 6 months in over 30% of the patients who undergo PTCA. Before informed therapeutic choices can be made between the two procedures, controlled studies are needed to compare objectively the benefits and risks of an initial strategy of PTCA versus CABG. The Bypass Angioplasty Revascularization (BARI) was designed to compare these strategies and provide scientific evidence upon which patients and physicians could base decisions for choosing one or the other therapy. The economic impact alone of BARI will be significant considering the large amount of health care dollars spent on coronary artery disease each year. BARI was designed to compare the benefits and risks of PTCA and CABG through random assignment of revascularization strategy and systematic follow-up over five or more years. Investigators randomized a total of 1829 patients (129 at Duke) and have followed these patients with telephone contact, clinical evaluations, exercise treadmill tests, lipid panels and in-depth socioeconomic surveys. In addition, 310 randomized patients at seven participating sites underwent coronary angiography at 10-14 months following the baseline angiogram.

Project Start
Project End
Budget Start
Budget End
Support Year
35
Fiscal Year
1996
Total Cost
Indirect Cost
Askie, Lisa M; Darlow, Brian A; Finer, Neil et al. (2018) Association Between Oxygen Saturation Targeting and Death or Disability in Extremely Preterm Infants in the Neonatal Oxygenation Prospective Meta-analysis Collaboration. JAMA 319:2190-2201
Srinivasan, Lakshmi; Page, Grier; Kirpalani, Haresh et al. (2017) Genome-wide association study of sepsis in extremely premature infants. Arch Dis Child Fetal Neonatal Ed 102:F439-F445
Denson, Lee A; McDonald, Scott A; Das, Abhik et al. (2017) Early Elevation in Interleukin-6 is Associated with Reduced Growth in Extremely Low Birth Weight Infants. Am J Perinatol 34:240-247
James, Jennifer; Munson, David; DeMauro, Sara B et al. (2017) Outcomes of Preterm Infants following Discussions about Withdrawal or Withholding of Life Support. J Pediatr 190:118-123.e4
Younge, Noelle; Goldstein, Ricki F; Bann, Carla M et al. (2017) Survival and Neurodevelopmental Outcomes among Periviable Infants. N Engl J Med 376:617-628
Archer, Stephanie Wilson; Carlo, Waldemar A; Truog, William E et al. (2016) Improving publication rates in a collaborative clinical trials research network. Semin Perinatol 40:410-417
Ahmed, Zuhayer; Prasad, Indrajit; Rahman, Hafizur et al. (2016) A Male with Extreme Subcutaneous Insulin Resistance: A Case Report. Rom J Diabetes Nutr Metab Dis 23:209-213
Phelps, Dale L; Ward, Robert M; Williams, Rick L et al. (2016) Safety and pharmacokinetics of multiple dose myo-inositol in preterm infants. Pediatr Res 80:209-17
Barroso, Julie; Leserman, Jane; Harmon, James L et al. (2015) Fatigue in HIV-Infected People: A Three-Year Observational Study. J Pain Symptom Manage 50:69-79
Stafford-Smith, Mark; Li, Yi-Ju; Mathew, Joseph P et al. (2015) Genome-wide association study of acute kidney injury after coronary bypass graft surgery identifies susceptibility loci. Kidney Int 88:823-32

Showing the most recent 10 out of 128 publications